IGC Pharma, Inc. (IGC)
(Delayed Data from AMEX)
$0.45 USD
0.00 (-0.24%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $0.44 -0.01 (-2.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IGC 0.45 0.00(-0.24%)
Will IGC be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for IGC based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for IGC
Rising High: Exclusive talk with software developer Rank Really High
Election 2024: Where To Put Your Money Ahead of the Vote
Here's What You Missed in Cannabis, Psychedelics This Week
IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target
IGC Pharma initiated with bullish view at Alliance Global Partners, here's why